Treatment of ADHD: Guanfacine Extended Release in ADHD
Investigators at Massachusetts General Hospital, Boston, MA, performed a multicenter, 9-week, double-blind, placebo-controlled, dose-optimization study of guanfacine extended release (GXR, <4 mg/d) adjunctive to a long-acting psychostimulant for ADHD continued in 461 subjects.
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Pediatric Neurology Briefs Publishers
2014-08-01
|
| coleção: | Pediatric Neurology Briefs |
| Assuntos: | |
| Acesso em linha: | https://www.pediatricneurologybriefs.com/articles/129 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|